tradingkey.logo

DaVita Inc

DVA
111.450USD
-1.140-1.01%
Handelsschluss 01/09, 16:00ETKurse um 15 Minuten verzögert
7.91BMarktkapitalisierung
11.23KGV TTM

DaVita Inc

111.450
-1.140-1.01%

mehr Informationen über DaVita Inc Unternehmen

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Inc Informationen

BörsenkürzelDVA
Name des UnternehmensDaVita Inc
IPO-datumOct 31, 1995
CEORodriguez (Javier J)
Anzahl der mitarbeiter76000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse2000 16th St
StadtDENVER
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl80202-5117
Telefon13105362668
Websitehttps://www.davita.com/
BörsenkürzelDVA
IPO-datumOct 31, 1995
CEORodriguez (Javier J)

Führungskräfte von DaVita Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.98K
+411.00%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.44K
+411.00%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
13.08K
-7501.00%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.23K
+411.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Andere
24.33M
0.71%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Andere
24.33M
0.71%

Aktionärsstatistik

Aktualisiert: Thu, Dec 4
Aktualisiert: Thu, Dec 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Andere
39.97%
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Andere
39.97%
Aktionärstypen
Aktionäre
Anteil
Holding Company
44.99%
Investment Advisor
25.80%
Investment Advisor/Hedge Fund
14.44%
Hedge Fund
5.47%
Individual Investor
5.06%
Research Firm
2.42%
Pension Fund
2.16%
Bank and Trust
0.87%
Sovereign Wealth Fund
0.35%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1272
36.41M
51.56%
-4.55M
2025Q3
1299
36.28M
57.59%
-1.47M
2025Q2
1288
37.75M
54.27%
+725.11K
2025Q1
1275
37.24M
54.43%
-4.83M
2024Q4
1234
39.31M
53.45%
-1.10M
2024Q3
1192
40.91M
54.63%
-1.68M
2024Q2
1162
42.62M
55.55%
-1.85M
2024Q1
1146
44.41M
55.70%
-4.44M
2023Q4
1143
45.66M
55.03%
+259.36K
2023Q3
1139
46.32M
54.25%
+1.22M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Berkshire Hathaway Inc.
31.76M
44.98%
-401.51K
-1.25%
Oct 27, 2025
The Vanguard Group, Inc.
4.21M
5.96%
-518.53K
-10.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
3.39%
-242.29K
-9.18%
Sep 30, 2025
Weschler (R Ted)
2.18M
3.09%
--
--
Aug 06, 2024
State Street Investment Management (US)
1.83M
2.6%
-258.50K
-12.35%
Sep 30, 2025
Invesco Capital Management LLC
1.40M
1.98%
+57.02K
+4.25%
Sep 30, 2025
Gates Capital Management, Inc.
1.19M
1.69%
+91.40K
+8.32%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.09M
1.54%
+88.06K
+8.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.45%
-86.31K
-7.78%
Sep 30, 2025
LSV Asset Management
927.03K
1.31%
-13.70K
-1.46%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Aztlan Global Stock Selection DM SMID ETF
2.59%
State Street SPDR S&P Health Care Services ETF
1.84%
Strategas Global Policy Opportunities ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.47%
Pacer US Cash Cows Growth ETF
1.02%
AdvisorShares Insider Advantage ETF
0.95%
Global X Aging Population ETF
0.75%
iShares U.S. Healthcare Providers ETF
0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.67%
LeaderShares AlphaFactor US Core ETF
0.66%
Mehr Anzeigen
Aztlan Global Stock Selection DM SMID ETF
Anteil2.59%
State Street SPDR S&P Health Care Services ETF
Anteil1.84%
Strategas Global Policy Opportunities ETF
Anteil1.64%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.47%
Pacer US Cash Cows Growth ETF
Anteil1.02%
AdvisorShares Insider Advantage ETF
Anteil0.95%
Global X Aging Population ETF
Anteil0.75%
iShares U.S. Healthcare Providers ETF
Anteil0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Anteil0.67%
LeaderShares AlphaFactor US Core ETF
Anteil0.66%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von DaVita Inc?

Die fünf größten Anteilseigner von DaVita Inc sind:
Berkshire Hathaway Inc. hält 31.76M Aktien, was 44.98% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 4.21M Aktien, was 5.96% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 2.40M Aktien, was 3.39% der Gesamtaktien entspricht.
Weschler (R Ted) hält 2.18M Aktien, was 3.09% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 1.83M Aktien, was 2.60% der Gesamtaktien entspricht.

Was sind die drei wichtigsten Anteilseigner-Typen von DaVita Inc?

Die drei wichtigsten Anteilseigner-Typen von DaVita Inc sind:
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

Wie viele Institutionen halten Anteile an DaVita Inc (DVA)?

Mit Stand vom 2025Q4 halten 1272 Institutionen Anteile an DaVita Inc, mit einem Gesamtmarktwert von etwa 36.41M, was 51.56% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -6.02% gestiegen.

Was ist die größte Einnahmequelle von DaVita Inc?

Am FY2025Q3 erzielte das Geschäft mit Patient service - Medicare and Medicare Advantage für DaVita Inc den höchsten Umsatz in Höhe von 1.72B, was 50.15% des Gesamtumsatzes entspricht.
KeyAI